Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT04093310
Other study ID # RC19_0179
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date January 17, 2020
Est. completion date May 31, 2024

Study information

Verified date June 2023
Source Nantes University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Bartholin's gland abscess is a condition requiring emergency consultation. Placement of a Word catheter, which is a minor technique used in France as a treatment of bartholin's Abscess, can be done in an emergency room without hospitalization. Actually, incision-drainage, which is the most widespread treatment in France, is performed on day surgery with or without overnight hospitalization. Our hypothesis is that the use of Word catheter compared to incision-drainage would not modify the quality of life of the patients but would allow a saving of up to 3 M€ per year in France.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 302
Est. completion date May 31, 2024
Est. primary completion date May 31, 2024
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria: Abscess of Bartholin's gland Patient able to understand the protocol Patient who signed informed consent Patient with social insurance Exclusion Criteria: Spontaneous fistulization of the abscess before surgical treatment Abscess volume under 3 ml Medical treatment which avoid incision or word catheter placement patients under guardianship Unable to complete questionnaires Patients not affiliated to social protection regimen Pregnant or post-partum women (until 4 weeks after delivery)

Study Design


Related Conditions & MeSH terms

  • Abscess
  • Bartholin's Gland Abscess Treatment

Intervention

Device:
Word Catheter
Use of the Word catheter to remove the Bartholin's abscess
Procedure:
Incision-drainage
Incision-drainage to remove the Bartholin's abscess

Locations

Country Name City State
France Chu Angers Angers
France Bordeaux University Hospital Bordeaux
France CHU CAEN Caen
France Ch Antoine Beclere Clamart
France Chu Estaing Clermont-Ferrand
France Institut Franco Britannique Levallois-Perret
France Chu Lille Lille
France Nancy University Hospital Nancy
France Chu Nantes Nantes
France Chu Caremeau Nîmes
France Ch Kremlin Bicetre Paris
France Chu Cochin Paris
France Chu Robert Debre Paris
France Chi Poissy Poissy
France Chu Poitiers Poitiers
France Rennes University Hospital Rennes
France Chu Toulouse Toulouse

Sponsors (1)

Lead Sponsor Collaborator
Nantes University Hospital

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary cost-utility ratio, according to the societal perspective of the of the management of Bartholin's gland abscess by the Word catheter compared to the incision-drainage The utility will be measured by:
Quality Adjusted Life Year (QALYs) as estimated from responses to the Euroqol-5 Dimensions (EQ-5D 5L) health-related quality of life questionnaire. The questionnaire focuses on 5 dimensions: mobility, personal autonomy, current activities, pain/discomfort and anxiety/depression. For each of these dimensions, 5 answers are possible.
The costs will be measured by the addition of the following costs:
Outpatient resource consumption collected in a declarative patient questionnaire. Hospital care resources using the the database of the Medicalised Information System Program of each recruiting site
12 months
Secondary Budget impact analysis for the health insurance point of view in case of diffusion of the Word catheter Comparison of intervention costs on the study sample and projection of these costs over 5 years, from the health insurance and hospital perspectives 5 years
Secondary Non inferiority evaluation of Word catheter vs. Incision drainage in terms of pain Pain numeric scale from 0 to 10 at baseline and day 1
Secondary Non inferiority evaluation of Word catheter versus incision-drainage in terms of recurrence rate Number of homolateral recurrences of Bartholin's abscess, declared by the patient 12 months
Secondary Comparison of Word catheter versus incision-drainage concerning pain Pain numeric scale from 0 to 10 12 months
Secondary Comparison of Word catheter versus incision-drainage concerning management time Date and time of patient initial management (randomization) Date and time of the beginning of the procedure date and time of the end of the procedure date and time of the hospital departure Day 0 (procedure day), Day 1
Secondary Comparison of Word catheter versus incision-drainage in terms of complications number of complications related to the procedure (healing complications, infection, lost of the Word catheter), contro-lateral Bartholin's abscess occurrence 12 months
Secondary Comparison of Word catheter versus incision-drainage in terms of surgical failure Word catheter: insertion failure, loss, removal decision (from the patient or the surgeon) Incision-drainage: incomplete drainage Immediate post-operative (D0) and one month
Secondary Comparison of Word catheter versus incision-drainage in terms of impact on sexual activity Score of the Female Sexual Function Index: self-questionnaire including 19 questions assessing different parameters of the sexual activity Baseline, one month, 6 months and 12 months
Secondary Comparison of Word catheter versus incision-drainage in terms of quality of life using the SF-12-HS Short-Form-12-Health-Survey questionnaire score: self-questionnaire including 12 questions measuring different aspects of quality of life Baseline, one month, 6 months and 12 months
Secondary Comparison of Word catheter versus incision-drainage in terms of quality of life using the EQ-5D EQ-5D 5L score (described in primary outcome) Baseline, one day, one month, 3 months, 6 months, 9 months and 12 months
Secondary Comparison of Word catheter versus incision-drainage in terms global patient impression and improvement Patient Global Impression and Improvement (PGI-I) global index used to rate the response of a condition to a therapy (transition scale). It is a single question asking the patient to rate their global condition now, as compared with how it was prior to before beginning treatment on a scale from 1 - very much better to 7 - very much worse One day, one month, 3 months, 6 months, 9 months and 12 months